ANMI

ANMI ANMI SA, a Radiopharmaceutical fully owned by Telix Pharmaceutical, develops innovative solutions in the field of Nuclear Medicine.
(2)

ANMI SA is an API supplier for radiometals labeled radiopharmaceuticals and a global service provider in the nuclear medicine field field located in Liège, Belgium. ANMI has developed innovative solutions to facilitate the synthesis of these theranostic radiopharmaceuticals and to ease their daily production in hospitals. These solutions are scalable and adaptable to a large range of peptide-based and non peptide-based radiopharmaceutical precursors. The company expertise based on a strong market and regulatory knowledge of the nuclear medicine area can provide premium quality product and services. ANMI vision is focus on increasing patient access to new highly specific theranostic radiopharmaceuticals through straight forward and cost effective production processes.

Adres

Rue De Hermée, 255
Herstal
4040

Telefoon

+3243785047

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer ANMI nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar ANMI:

Snelkoppelingen

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram